Biliary Stents Market (By Type: Metal, Plastic; By Application: Bilio-pancreatic Leakages, Pancreatic Cancer; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

The global biliary stents market size was estimated at around USD 148.1 million in 2023 and it is projected to hit around USD 242.39 million by 2033, growing at a CAGR of 5.05% from 2024 to 2033. The biliary stents market is expanding significantly, primarily because chronic liver illnesses and biliary disorders are becoming more common.

Key Pointers

• North America region led the market with the largest market share of 44% in 2023.
• Asia Pacific region is predicted to grow at the remarkable CAGR during the forecast period.
• By Type, the metal biliary stents category secured the largest share of revenue of 67% in 2023.
• By Application, the gallstones segment dominated the revenue share in 2023.
• By Application, the benign biliary strictures segment is projected to record the fastest CAGR over the forecast period.
• By End-use, the hospitals segment generated the maximum market share in 2023.

Biliary Stents Market Overview

The biliary stents market is a pivotal segment within the broader landscape of medical devices, addressing critical medical needs related to the biliary system. Biliary stents, designed to alleviate obstructions and support the normal flow of bile, have become indispensable tools in the management of various biliary disorders. This overview aims to provide a comprehensive insight into the key aspects defining the biliary stents market, encompassing market size, growth drivers, challenges, and notable trends.

Biliary Stents Market Growth

The growth of the biliary stents market is propelled by several key factors contributing to its expansion. A burgeoning aging population, coupled with an increased prevalence of biliary disorders, has significantly driven the demand for biliary stents. Advances in medical technology, particularly in the design and materials used for stent manufacturing, have played a pivotal role in enhancing their efficacy and patient outcomes. Moreover, the rising adoption of minimally invasive procedures has fueled the demand for biliary stents as they become integral in treating conditions such as biliary strictures and obstructive jaundice. The continuous emphasis on research and development activities by industry players to introduce innovative products further stimulates market growth. Additionally, the expanding awareness among healthcare professionals and patients about the benefits of biliary stent interventions contributes to the overall market expansion. The convergence of these factors creates a conducive environment for sustained growth within the biliary stents market.

Report Scope of the Biliary Stents Market

Biliary Stents Market Dynamics

Drivers

• Rising Minimally Invasive Procedures: The global trend towards minimally invasive surgical procedures has significantly contributed to the growth of the biliary stents market. Biliary stents play a crucial role in these procedures, offering a less invasive yet effective solution for conditions like obstructive jaundice.
• Increasing Prevalence of Biliary Diseases: The overall increase in the prevalence of biliary diseases, including tumors and strictures, serves as a major driver for the biliary stents market. The need for therapeutic interventions to manage and alleviate these conditions propels the demand for biliary stents.

Restraints

• Limited Awareness in Developing Regions: Despite the global prevalence of biliary disorders, awareness regarding biliary stent interventions may be limited in certain developing regions. This lack of awareness among healthcare professionals and patients can impede the widespread adoption of biliary stents.
• Risk of Complications and Adverse Events: The use of biliary stents is not without associated risks, including complications such as stent migration, infection, or tissue overgrowth. Concerns about potential adverse events may influence both patient and clinician decisions, impacting the acceptance of biliary stent procedures.

Opportunities

• Rising Demand for Bioresorbable Stents: The evolving field of biliary stents presents an opportunity for innovation, particularly in the development of bioresorbable stents. The increasing demand for stents that can be absorbed by the body over time offers a promising avenue for growth within the biliary stents market.
• Patient-Centric Product Development: An opportunity exists for manufacturers to engage in patient-centric product development, addressing the specific needs and preferences of patients undergoing biliary stent procedures. Customizing products for enhanced comfort and efficacy can create a competitive edge in the market.

Type Insights

The metal biliary stents category secured the largest share of revenue of 67% in 2023. A notable breakthrough in endoscopic treatment for obstructive biliary issues was the introduction of fully covered self-expandable metal stents (FCSEMS), highlighted in an October 2021 NCBI article. The widespread adoption of FCSEMS can be attributed to several factors. Their significant diameter and the synthetic covering surrounding the tubular mesh contribute to prolonged stent patency, boosting effectiveness and reducing the risk of tissue hyperplasia and tumor ingrowth.

The polymer stents category is expected to experience the most rapid market growth during the forecast period. Continuous innovation and advancements in polymer technology are significant drivers, leading to the creation of stents with enhanced flexibility and biocompatibility. Polymer stents provide a viable alternative to traditional metal stents, as they are often more easily deployable and adaptable to various anatomical structures. Additionally, the inherent non-metallic nature of polymers reduces the risk of interference with imaging modalities such as MRI.

Application Insights

The gallstones segment dominated the revenue share in 2023. The escalating incidence of gallstone-related issues underscores the need for effective and minimally invasive treatment alternatives. Biliary stents specifically designed for managing gallstones offer a targeted approach, assisting in symptom alleviation and promoting smoother bile flow. Advancements in stent technology, encompassing enhanced materials and design, contribute to heightened efficacy in addressing complications associated with gallstones. The increasing awareness among healthcare professionals and patients about the advantages of utilizing stents for gallstone management significantly amplifies the demand for these specialized devices. Consequently, the gallstone stents segment is positioned for sustained growth within the broader market.

The benign biliary strictures segment is projected to record the fastest CAGR over the forecast period. The demand for effective and minimally invasive treatment options has spurred the development and adoption of specialized biliary stents tailored to address benign strictures. Technological progress in stent design and materials enhances efficacy and durability, offering prolonged relief for patients with benign biliary strictures.

End-use Insights

The hospitals segment generated the maximum market share in 2023. Hospitals play a pivotal role in propelling the growth of the biliary stents industry, serving as central hubs for comprehensive medical care. With a multitude of medical services and specialized departments, hospitals are key players in addressing a broad spectrum of patient needs. Specifically in the realm of biliary stents, hospitals provide the essential infrastructure and expertise required for intricate procedures and interventions.

The ambulatory surgical centers (ASCs) segment is poised for rapid growth during the forecast period. Ambulatory surgical centers are integral to the biliary stents industry, offering a convenient and efficient setting for outpatient procedures, including those involving biliary stents. ASCs present an alternative to traditional hospital settings, enabling same-day surgical interventions. Patients benefit from streamlined processes and specialized care within ASCs, contributing to the increased accessibility and utilization of biliary stent procedures.

Regional Insights

North America region dominated the market with the largest market share of 44% in 2023, driven by the escalating demand for minimally invasive procedures in the region. The American Cancer Society reports a noteworthy healthcare concern related to bile duct cancer (cholangiocarcinoma), a rare condition with approximately 8,000 annual diagnoses in the U.S. In addressing this unique healthcare challenge, biliary stents emerge as crucial therapeutic tools for managing conditions linked to bile duct cancer, including obstructions or narrowing induced by tumors. The prevalence of bile duct cancer cases establishes a specific and substantial demand for biliary stents, underscoring their integral role in North America's healthcare landscape.

The Asia Pacific region is predicted to grow at the remarkable CAGR during the forecast period, propelled by a surge in patient numbers and the expanding presence of prominent healthcare providers in rapidly developing economies such as India and China. Expansion opportunities arise from the increasing demand for healthcare services in the region, coupled with government support for advancements in healthcare utilization. For instance, the Indian government's financial assistance to indigent cancer patients through the Tertiary Care Cancer Centers (TCCC) scheme, which aims to strengthen or establish 20 State Cancer Institutes (SCI) and 50 TCCCs, is expected to stimulate the demand for biliary stent devices, contributing to the overall growth of the region.

Key Companies

• Boston Scientific
• Cook Group
• ENDO-FLEX GmbH
• Olympus Corporation
• B Braun Melsungen
• CONMED Corporation
• M.I Tech
• Becton, Dickinson & Company
• Medtronic plc
• Cardinal Health
• Merit Medical System

Biliary Stents Market Segmentations:

By Type

• Metal
• Polymer
• Plastic

By Application

• Bilio-pancreatic Leakages
• Pancreatic Cancer
• Benign Biliary Structures
• Gallstones
• Others

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa